Which Tests Find the Cause of Peripheral Neuropathy? Blood Work, Nerve Studies and Imaging

The first thing many people notice is not pain but a wrong kind of quiet. Toes that no longer register the cold bathroom tile. A sock that bunches under the arch and goes unnoticed until evening. Then a tingle, a burn, a sense that the feet belong to someone else. By the time they sit down with a clinician, the question has sharpened: not just what is this, but why.

That second question matters more than most people expect. Peripheral neuropathy, damage to the nerves that run outside the brain and spinal cord, has more than a hundred recognized causes, and the plan for managing it depends heavily on which one is at work. The tests for peripheral neuropathy cause are built to narrow that list, step by step.

What follows is a plain account of those tests: what each one measures, why it is ordered, what it feels like, and what a normal result does and does not rule out.

Why does finding the cause of peripheral neuropathy change what happens next?

Numb feet look the same on the surface whether the culprit is high blood sugar, a vitamin deficiency, an inherited condition or a medication. Underneath, the mechanisms differ, and so does the response. A deficiency can be replaced. A drug can be reviewed by the prescriber. An immune-driven neuropathy may respond to treatments that would do nothing for a diabetic one. In a few cases the neuropathy is the first visible sign of something elsewhere in the body, such as an abnormal blood protein, and finding it early matters for reasons that have little to do with the feet.

The National Institute of Neurological Disorders and Stroke counts more than 100 types of peripheral neuropathy and estimates that roughly 20 million people in the United States live with some form of it. Diabetes is the single most common cause in high-income countries. Yet even in a person with diabetes, clinicians are taught not to assume. The NHS and Mayo Clinic both describe a baseline set of checks because a second, treatable cause can sit alongside the obvious one.

There is also a practical reason to be thorough. Nerve fibers regrow slowly, on the order of millimeters per week, and some damage does not reverse. Removing or controlling the cause early gives the nerves their best chance of stabilizing. That is why the workup is front-loaded: history, examination and a tier of blood tests first, electrical studies next, and more specialized tests only when the pattern demands them. Each step is designed to answer a specific question rather than to search blindly.

How does a neuropathy workup actually happen, from first visit to results?

Most of the diagnostic work is done before a single needle is drawn. The clinician will ask when the symptoms began, whether they started in both feet at once or in one limb, whether they are mostly numbness, mostly pain, or include weakness, and whether anything else has changed: balance, bowel or bladder habits, dizziness on standing, sweating. They will ask about alcohol intake, diet, family history, work exposures, past chemotherapy and every medicine and supplement in the cabinet.

The examination then maps the problem. Reflexes at the ankles and knees are tapped with a small hammer. Light touch, pinprick, vibration from a tuning fork and the sense of where a toe is pointing are tested systematically. Strength is checked muscle by muscle. Gait and balance are observed. From this, the clinician builds a pattern. A symmetric, stocking-and-glove loss that starts in the toes suggests a length-dependent process, where the longest nerve fibers fail first. Patchy loss in several separate nerves points toward something quite different, such as inflammation of blood vessels supplying the nerves.

Only then are tests chosen. The Mayo Clinic describes the usual order: blood tests, then nerve function tests, then imaging or biopsy when indicated. A first round of blood work can be drawn the same day. Nerve conduction studies and electromyography, which are described below, are commonly scheduled separately in a neurophysiology laboratory. Results from these steps may arrive over days to weeks, and the clinician assembles them into a working diagnosis, sometimes a firm one and sometimes a shortlist that needs a second tier of tests to settle.

Which blood tests for neuropathy are usually ordered first?

The first tier is deliberately broad, because its job is to catch the common and the fixable. The NHS lists checks for diabetes, vitamin B12 deficiency, and thyroid, kidney and liver function among the usual starting points. Each has a clear link to nerve damage.

Blood glucose and glycated hemoglobin, usually written HbA1c, which reflects average blood sugar over roughly the past three months, screen for diabetes and prediabetes. Vitamin B12 is measured because the vitamin is needed to maintain myelin, the fatty insulation around nerve fibers; the NIH Office of Dietary Supplements notes that deficiency can cause numbness and tingling in the hands and feet, that absorption falls with age, and that long-term use of certain diabetes and acid-reducing medicines lowers levels. When B12 sits in a gray zone, methylmalonic acid, a substance that rises when B12 is functionally short, may be added.

Thyroid-stimulating hormone picks up an underactive thyroid, which can slow nerve conduction. Kidney function tests matter because waste products that build up in advanced kidney disease are toxic to nerves. Liver tests, a full blood count and inflammatory markers round out the picture.

One test that surprises people is serum protein electrophoresis, often with immunofixation. These look for a monoclonal protein, an abnormal antibody produced by a single clone of plasma cells. Mayo Clinic includes it in the standard panel because such proteins can coat nerves and trigger damage, and because they occasionally signal a blood disorder that needs its own assessment. Depending on the story, a clinician may add tests for vitamin B6, vitamin E, copper, HIV, hepatitis B and C, Lyme disease, syphilis or specific autoimmune antibodies. None of these are routine for everyone; each is chosen because something in the history made it plausible.

What does a nerve conduction study for neuropathy actually measure?

A nerve conduction study is an electrical test of how fast and how strongly a nerve carries a signal. Small flat electrodes are taped to the skin over a nerve, a brief pulse is delivered at one point, and the response is recorded a measured distance away. The machine calculates speed in meters per second and the size of the response, a stand-in for how many fibers are still working.

Those two numbers tell a story. According to MedlinePlus, the test is used to detect nerve damage and to distinguish problems in the nerve itself from problems in muscle. Clinically, it also separates two broad categories. When speed is preserved but the response is small, the axons, the long cable-like cores of the nerve fibers, are being lost; this axonal pattern is typical of diabetes, toxins and many metabolic causes. When speed is markedly slowed or signals are blocked along the way, the myelin insulation is the problem; this demyelinating pattern raises the possibility of an immune-mediated neuropathy, which changes the subsequent tests and the conversation about treatment.

The pulses feel like a sudden tap or a quick static shock. Most people describe them as startling rather than painful. Cold hands and feet slow nerve conduction, so a technician may warm the limb first; this is why patients are often asked to avoid lotions on the day and to arrive with warm extremities. The number of nerves tested depends on the question. A length-dependent neuropathy usually calls for several nerves in the legs and at least one or two in the arms for comparison.

One limit deserves emphasis. The study measures large, fast-conducting fibers. Small fibers, which carry pain and temperature, are invisible to it, a point that becomes central later in the workup.

Is the EMG test for nerve damage painful, and what does it add?

Electromyography, or EMG, records the electrical activity of muscle. A very thin needle electrode is inserted into a muscle, and the clinician listens and watches as the muscle rests and then contracts gently. It is usually performed in the same session as the nerve conduction study, by a neurologist or physiatrist trained in electrodiagnosis, and the two tests are reported together.

The question EMG answers is whether a muscle has lost some of its nerve supply, and if so, how recently. Johns Hopkins Medicine describes it as a way to assess the health of muscles and the nerve cells that control them. A muscle cut off from its nerve develops spontaneous electrical discharges within weeks, and over months the surviving nerve fibers sprout to adopt orphaned muscle fibers, producing recognizably larger signals. So the pattern on EMG can suggest whether the process is active and ongoing or old and settled, which bears directly on how urgently the cause needs to be found.

EMG also helps with geography. It can show whether damage is confined to the distribution of a single nerve, a nerve root leaving the spine, or a widespread pattern consistent with a generalized neuropathy. This matters because a compressed nerve root in the lower back can mimic neuropathy, and the two call for different next steps.

On discomfort: the needle is far finer than one used to draw blood, and no electricity is delivered through it. People commonly report a brief pinch and a dull ache during contraction. Minor bruising can follow. Anyone taking a blood thinner, or who has a pacemaker or similar device, should tell the laboratory in advance; the test is often still possible, but the team may adjust the approach.

Tests for peripheral neuropathy cause: what each one answers

Laid side by side, the tests look less like a gauntlet and more like a set of tools, each suited to a particular question. The table below summarizes the main ones described by MedlinePlus, Mayo Clinic and the NHS.

Test	Main question it answers	What it involves	Typical place in the sequence
Blood tests (glucose, HbA1c, B12, thyroid, kidney, liver, protein electrophoresis)	Is a metabolic, nutritional or blood-protein cause present?	A standard blood draw	First tier, almost everyone
Nerve conduction study	Are large fibers damaged, and is the problem axonal or demyelinating?	Surface electrodes and small electrical pulses	Early, once blood work is under way
Electromyography (EMG)	Have muscles lost nerve supply, and is the process active?	Fine needle electrode in selected muscles	Usually alongside nerve conduction
Skin biopsy	Are small pain and temperature fibers reduced?	A punch of skin a few millimeters wide, usually from the leg	When electrical tests are normal but symptoms persist
Autonomic testing	Are the nerves controlling heart rate, blood pressure and sweating affected?	Breathing and tilt maneuvers with monitoring; sweat tests	When dizziness, digestive or sweating changes are reported
Imaging (MRI, CT, ultrasound)	Is a structural problem compressing or mimicking a nerve disorder?	Scanner or handheld probe, no needles unless contrast is used	Selective, based on pattern
Lumbar puncture, genetic tests, nerve biopsy	Is an inflammatory, inherited or infiltrative cause present?	Spinal fluid sample, blood sample, or small nerve sample	Second tier, specific indications

Two things stand out. The first tier is simple and widely available. The later tiers are reserved, not because they are unimportant, but because each carries more inconvenience or risk and only pays off when the earlier results have pointed the way.

When does imaging help find the cause of neuropathy, and when does it not?

People often assume a scan is the most powerful test available, and for many conditions that is true. For most peripheral neuropathies it is not. Magnetic resonance imaging and computed tomography show structures, and the diffuse, microscopic damage of a typical length-dependent neuropathy does not produce anything a scanner can see. Mayo Clinic lists imaging among the tests a clinician may order, with the qualifier that it is used to look for herniated discs, pinched nerves, tumors or other abnormalities affecting blood vessels and bones.

So imaging earns its place when the pattern is not a generalized neuropathy. If symptoms are confined to one limb, follow the path of a single nerve, or came on after an injury, an MRI of the spine or a targeted MRI of the limb can reveal a disc pressing on a nerve root or a mass compressing a nerve trunk. High-resolution ultrasound has become a useful bedside tool for exactly this: it can show a swollen nerve at a known entrapment point such as the wrist or the elbow, and can guide decisions about whether a nerve is compressed rather than diseased.

Imaging also appears in the second tier for a different reason. When blood tests reveal a monoclonal protein or inflammatory markers are high, scans of the skeleton or chest may be ordered to look for the underlying disorder rather than the nerves themselves. MRI of the nerve roots can sometimes show thickening or enhancement in inflammatory neuropathies, supporting a diagnosis suggested by electrical studies.

The practical message is that a clinician who does not order a scan is often following the evidence rather than cutting corners. A normal MRI in someone with symmetrical foot numbness would be expected, and it would not have moved the diagnosis forward.

What if nerve studies are normal? Skin biopsy and autonomic testing for small fiber neuropathy

Some of the most frustrating consultations happen when a person has burning, stabbing feet and a nerve conduction study that reads as entirely normal. The explanation is usually that the damage sits in small fibers, the thin, slow-conducting nerves that carry pain and temperature and that regulate sweating, blood vessel tone and gut movement. Standard electrical testing cannot see them.

A skin biopsy fills the gap. Under local anesthetic, a circular punch a few millimeters across removes a core of skin, typically from the lower leg and sometimes from the thigh for comparison. In the laboratory the sample is stained to reveal nerve endings, and the number of fibers crossing into the outer skin layer is counted and compared with reference values for age and sex. A reduced count supports small fiber neuropathy. Mayo Clinic lists this among the procedures used when nerve endings themselves need to be examined. The wound is small, closes on its own or with a single stitch, and heals over a week or two.

Autonomic testing addresses the same fibers from a different angle. The autonomic nervous system runs the body’s background functions, so a panel of maneuvers checks how heart rate and blood pressure respond to deep breathing, a forceful exhalation and standing or being tilted upright. Sweat tests measure whether the skin produces moisture normally when stimulated. Abnormal results confirm that the autonomic fibers are involved, which explains symptoms such as lightheadedness on standing or early fullness after meals that patients had not connected to their feet.

Finding small fiber neuropathy does not end the search for a cause. The same blood tests apply, with glucose tolerance testing often added, because impaired glucose handling that falls short of diabetes is a recognized association.

Second-tier tests: lumbar puncture, genetic testing and nerve biopsy

A smaller group of people reach a point where the pattern is unusual, the first tier is unrevealing, or the electrical studies suggest an inflammatory or inherited process. Three further tests then come into consideration, each with a specific purpose.

A lumbar puncture, also called a spinal tap, draws a small sample of cerebrospinal fluid, the clear liquid that bathes the brain and spinal cord, through a needle placed between the bones of the lower back. Mayo Clinic notes it is used to look for antibodies associated with neuropathy. In practice it is most useful when a demyelinating pattern on nerve conduction raises suspicion of an immune-mediated neuropathy; a raised protein level with few cells supports that diagnosis. Headache after the procedure is the most common side effect, and the team will explain how to reduce it.

Genetic testing is a blood test, but one that needs a conversation first. Inherited neuropathies tend to start young, progress slowly, and run in families, often with high-arched feet or hammer toes as clues. Modern panels test many genes at once. Mayo Clinic lists genetic testing among the options when a hereditary form is suspected. Because a result can carry implications for relatives, genetic counseling before and after is standard.

Nerve biopsy, the surgical removal of a short segment of a sensory nerve, usually at the ankle, is the most invasive option and is used sparingly. Mayo Clinic describes it as a way to look for abnormalities within the nerve itself. It is considered when vasculitis, inflammation of the blood vessels feeding the nerve, or infiltration by abnormal protein or cells is suspected and cannot be confirmed any other way. The sampled area is left permanently numb, so the decision is weighed carefully against what the result would change.

Who is usually tested right away, and who is usually asked to wait?

Not every tingling foot triggers the full sequence, and the pace is set by the history. The NHS advises seeing a general practitioner for early symptoms of neuropathy so that a cause can be looked for, and most people begin with examination and first-tier blood tests. From there, clinicians sort roughly into three groups.

Some people are moved quickly to electrical studies and specialist review. Weakness that is progressing over days or weeks, symptoms that started in the arms or face, marked asymmetry, difficulty walking, or new bladder, bowel or blood pressure problems all suggest something other than a slow metabolic neuropathy. A demyelinating pattern on nerve conduction, or a monoclonal protein on blood tests, also accelerates the workup because both can represent treatable or significant conditions.

A larger group is tested methodically but without urgency. Typical here is a person with long-standing diabetes, or with another clear and well-matched cause, whose symptoms are symmetrical, sensory and slowly evolving. Blood tests confirm the picture and exclude a second cause, and nerve conduction studies document the baseline. Specialist referral may follow if symptoms change or the picture does not fit.

A third group is asked to wait, in the sense of watchful monitoring rather than neglect. When a medication known to affect nerves has recently been started, the prescribing clinician may prefer to review that medicine before ordering more tests. When symptoms are mild, intermittent and the examination is normal, a repeat assessment after an interval can be more informative than an early battery of tests that are likely to read normal. The treating team weighs all of this, and the plan can change at any visit as new information arrives.

What do the days and weeks after neuropathy testing usually look like?

The testing phase has a rhythm of its own, and knowing it reduces the sense of drifting. Blood results are often available within days. Nerve conduction and EMG are typically reported on the day or shortly after, since the clinician performing them interprets the tracings directly. Skin biopsy results take longer, often one to several weeks, because the sample has to be processed and the fibers counted in a specialized laboratory; the ordering team will give a local estimate. Genetic panels and some antibody tests can take longer still.

Physically, recovery from the tests is modest. Mild bruising or aching at EMG needle sites fades within a few days. A skin biopsy site should be kept clean and dry as instructed and generally heals over one to two weeks. After a lumbar puncture, people are usually advised to rest, drink fluids and report a headache that worsens when upright.

Emotionally, this is the waiting room period, and it helps to use it. Keeping a brief daily note of symptoms, what makes them worse and any falls or near-falls gives the follow-up visit concrete material. Checking the feet each evening for cuts, blisters or pressure areas is worthwhile for anyone with reduced sensation, since injuries can go unnoticed. Mayo Clinic and the NHS both emphasize foot care and fall prevention as part of living with neuropathy regardless of cause.

The follow-up visit is where the pieces are assembled. A clear cause leads to a management plan aimed at that cause, with symptom control running alongside. An incomplete picture leads to a decision about second-tier tests or a period of monitoring. In either case, the conversation should end with a clear understanding of what has been excluded and what comes next.

What if every test comes back normal? The idiopathic neuropathy workup

A substantial minority of people complete a thorough workup and are told the cause is idiopathic, a medical word meaning no cause has been identified. The National Institute of Neurological Disorders and Stroke acknowledges that in a notable share of cases no specific cause is found. That label can land badly, as if the search was abandoned or the symptoms are being doubted. Neither is true.

Idiopathic neuropathy is a real diagnosis with a recognizable profile. It tends to appear in later middle age or beyond, to be mostly sensory, to start in the feet and to progress slowly over years. Electrical studies often show a mild axonal pattern or are normal, in which case a skin biopsy may show small fiber loss. The label is applied only after the first tier of blood tests, usually including glucose tolerance testing and a search for monoclonal protein, has been completed and reviewed.

Two caveats are worth holding onto. First, idiopathic does not mean permanent. New associations are described over time, and a clinician may revisit the diagnosis if symptoms change, if new test results emerge, or if a family history becomes apparent. Second, idiopathic does not mean untreatable. The management of nerve pain, balance training, foot protection and attention to general nerve health such as alcohol moderation and blood sugar control apply regardless of whether a cause was named.

Repeating the entire workup every year is not usually recommended. What is reasonable, and what many specialists suggest, is a periodic review with a focused reassessment of anything new. The conversation worth having is which specific findings would prompt further testing, so that both patient and clinician know what they are watching for.

What people often get wrong about tests for peripheral neuropathy cause

A few misunderstandings come up repeatedly, and clearing them away saves anxiety.

The first is that a normal nerve conduction study means the nerves are fine. It means the large fibers are conducting normally. Small fiber neuropathy, which produces some of the most intense burning pain, is routinely missed by this test and requires a skin biopsy or autonomic testing to confirm. A normal result is informative, not dismissive.

The second is that diabetes, once present, explains everything. Diabetes is the most common cause, but Mayo Clinic and the NHS both describe baseline blood tests for everyone precisely because a second cause, such as low vitamin B12, can coexist and is often correctable. The NIH Office of Dietary Supplements notes that long-term use of a common diabetes medicine can lower B12 levels, which makes the overlap more than theoretical.

The third is that an MRI should be the first test. Scans show structure. The microscopic damage of a generalized neuropathy is invisible to them, and imaging is reserved for patterns that suggest compression, injury or a mass.

The fourth is that EMG is a painful test to be avoided. It involves a very fine needle without electrical current, and most people describe brief discomfort rather than pain. Its ability to show whether damage is active or old is hard to replace.

The fifth is that a diagnosis of idiopathic neuropathy means the search was incomplete. It is reached only after a defined set of tests, and it describes a recognized condition with its own natural history.

Finally, home test kits and single supplement levels advertised as revealing the cause of neuropathy have no established role in guideline-based assessment. The evidence supports an ordered, clinician-led sequence, not a one-off panel.

Questions to ask your care team about neuropathy testing

Good questions turn a test into a shared plan. The following are the ones patients tend to wish they had asked, grouped by stage.

Before testing begins, it helps to ask what pattern the examination suggested and which causes are highest on the list. Ask which blood tests are being ordered and what each is looking for, and whether any medication or supplement in use is known to affect nerves. If a nerve conduction study and EMG are planned, ask whether both will be done, how to prepare, and whether blood thinners or implanted devices need to be mentioned to the laboratory in advance.

When results arrive, ask whether the electrical pattern was axonal or demyelinating and what that implies. Ask which causes have now been excluded and which remain possible. If something was borderline, such as a B12 level in the gray zone, ask whether a confirmatory test is planned. If a monoclonal protein was found, ask who will follow it up and how.

If the first tier was unrevealing, ask whether small fiber neuropathy is being considered and whether a skin biopsy or autonomic testing is appropriate. Ask what would prompt a lumbar puncture, genetic testing or referral to a neuromuscular specialist. If the label idiopathic is used, ask what specific changes in symptoms should trigger a fresh look.

Throughout, two questions anchor everything: what will this test change about my care, and what happens if it is normal? A clinician who can answer both is ordering tests with purpose, and a patient who asks both leaves with a clear map of where the process is heading. Writing the answers down, or bringing someone to listen, is a simple way to make sure nothing is lost between visits.

When to call your doctor: red-flag signs during a neuropathy workup

Most neuropathies evolve slowly, and the workup can proceed at a measured pace. Some situations should not wait for the next scheduled appointment, and a few call for emergency services.

Seek urgent care the same day if weakness is spreading or worsening over hours to days, particularly if it is climbing from the feet toward the hips or involving the hands and arms. Rapidly progressive weakness, especially after a recent infection, can indicate an acute inflammatory neuropathy that requires hospital assessment, and any difficulty breathing, swallowing or speaking alongside limb weakness is an emergency.

Contact the care team promptly, within a day or two, for new loss of bladder or bowel control, numbness in the saddle area between the legs, a fall or repeated near-falls, fainting or severe lightheadedness on standing, or symptoms that have changed character suddenly, such as numbness in one limb becoming weakness. New symptoms on one side only, or a sharply defined band of pain and numbness around the trunk, also deserve a timely call.

For anyone with reduced sensation in the feet, a cut, blister or sore that is not healing, or any area of redness, warmth or swelling, should be reported quickly. The NHS and Mayo Clinic highlight foot ulcers and unnoticed injuries as a major risk when sensation is impaired, since infection can take hold before pain signals it.

After specific procedures, call if a skin biopsy or nerve biopsy site becomes increasingly painful, red or weeps fluid, or if a headache after lumbar puncture is severe or persists beyond the period the team described. If a test result arrives that is unexpected or unclear, asking for an explanation is reasonable and does not need to wait. The treating team decides what each sign means in context; the patient’s job is to make sure they hear about it in time.

Frequently asked questions

What blood tests for neuropathy are done first?

The first round usually checks blood glucose and HbA1c for diabetes, vitamin B12, thyroid-stimulating hormone, kidney and liver function, a full blood count and serum protein electrophoresis for abnormal antibodies. These catch the most common and most correctable causes. Further tests such as vitamin B6, copper, infection screens or autoimmune antibodies are added only when the history makes them plausible.

Does a nerve conduction study for neuropathy hurt?

Most people find it startling rather than painful. Small electrical pulses delivered through skin electrodes feel like brief taps or static shocks. There are no needles in the nerve conduction portion. The limb may be warmed first, since cold slows conduction and can distort results. Any discomfort stops as soon as the pulses do, and there is no recovery time.

Is the EMG test for nerve damage safe if I take blood thinners?

It is often still possible, but the laboratory needs to know in advance. EMG uses a very fine needle placed in selected muscles, and people on anticoagulants have a slightly higher chance of bruising or a small bleed at the site. The clinician may choose fewer or more superficial muscles. Implanted devices such as pacemakers should also be mentioned beforehand.

Can an MRI show peripheral neuropathy?

Usually not. MRI shows structures, and the diffuse microscopic damage of a typical neuropathy is invisible to it. Imaging is ordered when the pattern suggests a compressed nerve root, an entrapped nerve, an injury or a mass, or when blood tests point to a disorder elsewhere in the body. A normal scan in someone with symmetrical foot numbness is the expected result.

Why would my nerve tests be normal when my feet burn?

Burning pain often comes from small nerve fibers, which standard nerve conduction studies cannot measure. These fibers carry pain and temperature and are assessed instead by a skin biopsy that counts nerve endings, or by autonomic tests of heart rate, blood pressure and sweating responses. A normal electrical study narrows the picture but does not mean the symptoms lack a physical cause.

What does an idiopathic neuropathy workup involve?

It means a defined set of tests has been completed without identifying a cause. That set typically includes the first-tier blood tests, often a glucose tolerance test, a search for monoclonal protein, and nerve conduction studies, sometimes with a skin biopsy. The label describes a recognized, usually slowly progressive condition and can be revisited if symptoms change or new findings appear.

How long do the results of neuropathy tests take?

Blood results commonly return within days. Nerve conduction and EMG findings are often explained on the day, since the examining clinician interprets them directly. Skin biopsy results take longer because fibers must be stained and counted in a specialized laboratory, and genetic panels or specialized antibody tests can take longer still. The ordering team will give a local estimate.

Do I need a lumbar puncture to diagnose neuropathy?

Most people do not. A lumbar puncture, which samples spinal fluid, is reserved for cases where nerve conduction suggests a demyelinating or inflammatory process, or where an infection or antibody-mediated condition is suspected. In those settings, protein and cell counts in the fluid can support or weaken the diagnosis. The decision rests with the neurologist based on the full picture.

If I have diabetes, why are other tests still needed?

Because a second cause can sit alongside diabetes and may be correctable. Vitamin B12 deficiency is a common example, and long-term use of a widely prescribed diabetes medicine is known to lower B12 levels. Thyroid problems, kidney disease and abnormal blood proteins can also coexist. Baseline tests confirm that diabetes is the explanation rather than assuming it.

Is genetic testing for neuropathy worth considering?

It is considered when the picture suggests an inherited form: symptoms beginning young, slow progression over decades, high-arched feet or hammer toes, and relatives with similar problems. Modern panels examine many genes from a single blood sample. Because results can affect family members, genetic counseling before and after testing is standard practice, and the specialist will discuss whether it fits your situation.

References

• Peripheral neuropathy: Diagnosis (NHS)
• Peripheral Neuropathy (NIH National Institute of Neurological Disorders and Stroke)
• Nerve conduction velocity (MedlinePlus Medical Encyclopedia)

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.